Eiger BioPharmaceuticals, Inc.
EIGRQ · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,454 | -$18,030 | -$20,695 | -$22,784 |
| Dep. & Amort. | $180 | $198 | $183 | $189 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $683 | $1,038 | $745 | $2,542 |
| Change in WC | -$1,679 | $2,122 | -$2,224 | -$3,952 |
| Other Non-Cash | $5,011 | $282 | $2,373 | $4,357 |
| Operating Cash Flow | -$13,954 | -$14,554 | -$22,035 | -$24,005 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $0 | -$17 | -$216 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$19,388 |
| Inv. Sales/Matur. | $12,000 | $19,000 | $29,863 | $32,987 |
| Other Inv. Act. | $12,000 | $19,000 | $29,863 | $13,599 |
| Investing Cash Flow | $11,999 | $19,000 | $29,846 | $13,383 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $15 | -$22 | $41 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $15 | -$22 | $41 |
| Financing Cash Flow | $7 | $15 | -$22 | $41 |
| Forex Effect | -$113 | $57 | $13 | -$36 |
| Net Chg. in Cash | -$2,061 | $4,518 | $7,802 | -$10,617 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $27,501 | $22,983 | $15,181 | $25,798 |
| End Cash | $25,440 | $27,501 | $22,983 | $15,181 |
| Free Cash Flow | -$13,955 | -$14,554 | -$22,052 | -$24,221 |